BN Business News
Cuir companaidh ris →

Business · 16/11/20261 min read

Tha Gumokimab (IL-17A) air aithris air NMPA le Akeso airson ankylosing spondylitis a' bheith air feagairt

Local automatic translation · Cànan tùsail an stòir

EDITORIAL ILLUSTRATIONBBusinessBN
Illustration generated by Business News; it is not a source photograph.

Summary

Tha Akeso, Inc. air a' phleannta a' bheith air feagairt air an 16 de Dheireadh mhìos 11, 2026 air HONG KONG /PRNewswire/.

Cànan tùsail an stòir: PR Newswire — Global News ReleasesOpen original release →

Explore insights

Business insights →